MRD / Regn No. : 20220000622 Date : 09/06/2026
Patient Name : Bhavanishree Jagadeesh Age & Gender : 44 Yrs. / Female
Contact No. : 9884585718 UHID :
Ht / Wt / BMI : 163 / 111 / 41.78 BP S / BP D : 110 / 80
Allergies : NKA Referred By : Bharathi Visweshwaran
   
Problem List : HYPOTHYROIDISM (08/Jun/2013) | OBESITY (08/Jun/2016) | PREDIABETES (13/Jun/2022) | VITAMIN D INSUFFICIENCY (13/Jun/2022) |
Subjective : LOST TO FOLLOW UP,DYSSOMNIA IMPROVED OFF MEDICATIONS,OFF LT4,AMENORRHEA FOR 2 MONTHS,SEIZURES IN MAY
Objective : NONE
Analysis : OBESITY,VITAMIN D INSUFFICIENCY,NAFLD INTERMEDIATE RISK,MILD TSH ELEVATION,MILD PROLACTIN ELEVATION,TYPE 2 DM
Plan : START SEMAGLUTIDE 0.25 MG,SEE ME IN 1 MONTH  
Salient Investigations : GLYCOSYLATED HEMOGLOBIN (HBA1C): 7.1 % | FREE T3: 3.02 ng/dL | FREE T4 : 1.23 ng/dL | TSH : 5.91 mIU/L
S# Generic (Trade) Name Route Dosage Usage Duration
1 INJECTION SEMAGLUTIDE
SEMALIX 0.25 MG
Medicine For DIABETES OBESITY MASLD CAD
SQ ONCE A WEEK AS DIRECTED NO RELATION TO FOOD
TILL NEXT VISIT
MAY CAUSE NAUSEA VOMITING OR EYE DISTURBANCE
       
Refill : 0 / Substitution:    
Education :
Next Visit : 09/Jul/2026
Tests Suggested For Next Visit : FBS 2HPP
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: